India Pesticides FY26 Revenue Surges 27.9% to ₹1,078 Crore; PAT Up 45.8%
India Pesticides Limited reported FY2026 revenue of ₹1,078 crore, a 27.9% YoY increase. PAT grew 45.8% to ₹120 crore. Q4 FY2026 revenue was ₹271 crore, up 28.5% YoY, with PAT up 40.6% to ₹31 crore. The company crossed the ₹1,000 crore revenue mark for the first time.
Significant revenue growth, crossing the ₹1,000 crore mark, and substantial profit increases are material events that are likely to impact investor sentiment and the company's stock price.
The company reported strong year-on-year growth in revenue and profit, exceeding a key revenue milestone, indicating positive financial performance.
India Pesticides Limited (IPL) announced its audited financial results for the quarter and year ended March 31, 2026. The company achieved a significant milestone by crossing the ₹1,000 crore revenue mark for the first time, with total revenue for FY2026 reaching ₹1,078 crore, a 27.9% year-on-year increase.
Consolidated EBITDA for the fiscal year rose by 44.7% to ₹194 crore, with EBITDA margins improving to 18.0%. Profit After Tax (PAT) saw a substantial growth of 45.8% year-on-year, reaching ₹120 crore. The company attributed this strong performance to robust domestic demand, healthy volume growth, improved operational efficiencies, and consistent execution across its business segments.
For the fourth quarter of FY2026, total income grew by 28.5% to ₹271 crore, while PAT increased by 40.6% to ₹31 crore. The management highlighted the continued focus on process optimization, backward integration, and strengthening customer relationships as key drivers for sustained growth.
IPL's R&D and project engineering capabilities remain a core strength, with multiple product registrations achieved during the year. The company is committed to expanding manufacturing capabilities, strengthening backward integration, and enhancing its presence in both domestic and international markets. Exports contributed 39% to the total revenue in FY2026, amounting to ₹408 crore.
What to do with a filing like this
India Pesticides Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by India Pesticides Limited. Read the original for the full detail.